A lack of association between the IKZF2 rs12619285 polymorphism and coronary heart disease

Experimental and Therapeutic Medicine

Volumn 9, Issue 4, 2015, Pages 1309-1313

  Ye, Huadan ^a   Hong, Qingxiao ^a   Li, Yirun ^a   Xu, Xuting ^a   Huang, Yi ^b   Xu, Limin ^a   Zhou, Annan ^a   Deng, Youping ^c   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b NINGBO FIRST HOSPITAL   (China)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coronary heart disease; IKZF2; Polymorphism; rs12619285

Indexed keywords

UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN HELIOS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; VERY ELDERLY;

EID: 84923003934     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2282     Document Type: Article

References (35)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757, 2006.
2. Mathers CD and Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442, 2006.
3. Libby P: Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
4. Kroupis C, Theodorou M, Chaidaroglou A, et al: The association between a common FCGR2A polymorphism and C reactive protein and coronary artery disease revisited. Genet Test Mol Biomarkers 14: 839-846, 2010.
5. Samani NJ, Erdmann J, Hall AS, et al; WTCCC and the Cardiogenics Consortium: Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453, 2007.
6. Mangino M and Spector T: Understanding coronary artery disease using twin studies. Heart 99: 373-375, 2013.
7. Dai J, Krasnow RE, Liu L, Sawada SG and Reed T: The association between postload plasma glucose levels and 38 year mortality risk of coronary heart disease: the prospective NHLBI Twin Study. PLoS One 8: e69332, 2013.
8. Vaccarino V, Goldberg J, Rooks C, et al: Post traumatic stress disorder and incidence of coronary heart disease: a twin study. J Am Coll Cardiol 62: 970-978, 2013.
9. Georgopoulos K, Winandy S and Avitahl N: The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol 15: 155-176, 1997.
10. Kelley CM, Ikeda T, Koipally J, et al: Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol: CB 8: 508-515, 1998.
11. Chio KD, Vodyanik M and Slukvin II: Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc 6: 296-313, 2011.
12. Engelmann MG, Kolbe T, Faul C and Steinbeck G: Hypereosinophilic syndrome associated with heterozygous factor V gene mutation: an unusual combination resulting in an acute coronary syndrome and recurrent cerebral stroke a case report. Angiology 55: 221-225, 2004.
13. Buysschaert ID, Grulois V, Eloy P, et al: Genetic evidence for a role of IL33 in nasal polyposis. Allergy 65: 616-622, 2010.
14. Akhabir L and Sandford A: Genetics of interleukin 1 receptor like 1 in immune and inflammatory diseases. Curr Genomics 11: 591-606, 2010.
15. Sekkach Y, Mekouar F, Jira M, et al: Durable efficacity and remission after treatment with imatinib mesylate for FIP1L1 PDGFRA transcript negative associated eosinophilic cardiomyopathy. Ann Pharm Fr 69: 277-281, 2011 (In French).
16. Singh RK, Gupta S, Dastidar S and Ray A: Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 85: 336-349, 2010.
17. Hogan SP, Rosenberg HF, Moqbel R, et al: Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38: 709-750, 2008.
18. Roivainen M, Viik Kajander M, Palosuo T, et al: Infections, inflammation, and the risk of coronary heart disease. Circulation 101: 252-257, 2000.
19. Sato Y, Fukunaga T, Hayashi T and Asada Y: Hypereosinophilic syndrome associated with occlusive coronary thrombosis and right ventricular thrombus. Pathol Int 58: 138-141, 2008.
20. Sakai T, Inoue S, Matsuyama TA, et al: Eosinophils may be involved in thrombus growth in acute coronary syndrome. Int Heart J 50: 267-277, 2009.
21. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41: 342-347, 2009.
22. Lian J, Huang Y, Huang RS, et al: Meta analyses of four eosinophil related gene variants in coronary heart disease. J Thromb Thrombolysis 36: 394-401, 2013.
23. No authors listed: Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59: 607-609, 1979.
24. Wang J, Chuang K, Ahluwalia M, et al: High throughput SNP genotyping by single tube PCR with Tm shift primers. Biotechniques 39: 885-893, 2005.
25. Yuan F, Xu J, Ji LD, et al: Application of Tm shift genotyping method in genetic studies. Yi Chuan 34: 1484-1490, 2012 (In Chinese).
26. Excoffier L and Lischer HE: Arlequin suite ver 3. 5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10: 564-567, 2010.
27. Sham PC and Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59: 97-105, 1995.
28. Dupont WD and Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials 11: 116-128, 1990.
29. Liu H, Huang XQ, Yang M, et al: MRAS genetic variation is associated with atherothrombotic stroke in the Han Chinese population. J Clin Neurol 9: 223-230, 2013.
30. Li X, He M, Zhu J, Yao P, Li X, Yuan J, Min X, Lang M, Yang H, Hu FB, Wu T and Wei S: Higher carbohydrate antigen 125 levels are associated with increased risk of coronary heart disease in elderly chinese: a population based case control study. PLoS One 8: e81328, 2013.
31. Jiang D, Zheng D, Wang L, et al: Elevated PLA2G7 gene promoter methylation as a gender specific marker of aging increases the risk of coronary heart disease in females. PLoS One 8: e59752, 2013.
32. National Center for Biotechnology Information: HapMap population allele frequency data. http://www. ncbi. nlm. nih. gov. Accessed February 7, 2014.
33. Halsell SR and Kiehart DP: Second site noncomplementation identifies genomic regions required for Drosophila nonmuscle myosin function during morphogenesis. Genetics 148: 1845-1863, 1998.
34. Jia LX, Qi GM, Liu O, Li TT, Yang M, Cui W, Zhang WM, Qi YF and Du J: Inhibition of platelet activation by clopidogrel prevents hypertension induced cardiac inflammation and fibrosis. Cardiovasc Drugs Ther 27: 521-530, 2013.
35. Paoletti R, Gotto AM Jr and Hajjar DP: Inflammation in atherosclerosis and implications for therapy. Circulation 109 (23 Suppl 1): III20 III26, 2004.